30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

Avanir Pharmaceuticals Inc (AVN)

Track

Stock chart
Ticker: AVN
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
OCAMPO CHRISTINE
Vice President, Finance
1 sale — total 58,072 USD
Sale 16 May 2014
Value US$1,254,719.35 | Price 345.52 | Shares 21,664
Buy 17 Dec 2013
Value US$1,634,896.66 | Price 344.09 | Shares 17,429
Buy 4 Nov 2013
Value US$41,895.00 | Price 4.19 | Shares 10,000
Buy 10 May 2012
Value US$7,992.00 | Price 2.96 | Shares 2,700
Buy 6 Mar 2012
Value US$13,473.00 | Price 2.69 | Shares 5,000
Buy 6 Mar 2012
Value US$7,794.90 | Price 2.60 | Shares 3,000
Sale 9 Nov 2010
Value US$5,773,920.00 | Price 4.81 | Shares 1,200,000
Sale 8 Nov 2010
Value US$227,592.60 | Price 5.10 | Shares 44,626
Sale 5 Nov 2010
Value US$1,597,376.57 | Price 4.80 | Shares 332,572
Sale 3 Nov 2010
Value US$6,332,539.43 | Price 4.52 | Shares 1,400,106
Sale 2 Nov 2010
Value US$5,800,399.75 | Price 4.49 | Shares 1,290,871
Sale 1 Nov 2010
Value US$13,273,424.18 | Price 5.36 | Shares 2,478,142
Sale 29 Oct 2010
Value US$7,215,646.62 | Price 5.06 | Shares 1,424,947
Sale 11 Oct 2010
Value US$1,093,444.90 | Price 3.52 | Shares 311,000
Sale 8 Oct 2010
Value US$836,791.63 | Price 3.47 | Shares 240,838
Sale 13 Jul 2010
Value US$583,143.00 | Price 3.53 | Shares 165,000
Sale 13 Oct 2009
Value US$1,220,111.05 | Price 2.23 | Shares 547,135
Sale 12 Oct 2009
Value US$905,547.40 | Price 2.12 | Shares 427,145
Sale 9 Oct 2009
Value US$1,979,591.52 | Price 2.46 | Shares 804,712
Sale 11 Aug 2009
Value US$783,937.62 | Price 3.37 | Shares 232,450
Sale 11 Aug 2009
Value US$201,690.00 | Price 4.05 | Shares 49,800
Sale 11 Aug 2009
Value US$3,200,949.60 | Price 3.58 | Shares 894,120
Sale 31 Jul 2009
Value US$3,080.00 | Price 2.20 | Shares 1,400
Sale 30 Jul 2009
Value US$326,445.24 | Price 2.29 | Shares 142,366
Sale 29 Jul 2009
Value US$331,245.30 | Price 2.28 | Shares 145,500
Sale 28 Jul 2009
Value US$295,713.99 | Price 2.42 | Shares 122,100
Buy 22 Oct 2008
Value US$5,088.00 | Price 0.48 | Shares 10,600
Buy 15 Oct 2008
Value US$3,167.85 | Price 0.49 | Shares 6,465
Buy 14 Oct 2008
Value US$16,150.00 | Price 0.50 | Shares 32,300
Buy 10 Oct 2008
Value US$33,097.95 | Price 0.45 | Shares 73,551
Buy 9 Oct 2008
Value US$19,864.80 | Price 0.48 | Shares 41,385
Buy 8 Oct 2008
Value US$57,192.00 | Price 0.50 | Shares 114,384
Buy 7 Oct 2008
Value US$10,232.64 | Price 0.48 | Shares 21,318
Buy 17 Sep 2008
Value US$330,573.60 | Price 0.80 | Shares 413,217
Buy 16 Sep 2008
Value US$13,214.12 | Price 0.76 | Shares 17,387
Buy 15 Sep 2008
Value US$207,781.65 | Price 0.85 | Shares 244,449
Buy 10 Sep 2008
Value US$43,773.73 | Price 0.91 | Shares 48,103
Buy 9 Sep 2008
Value US$134,688.00 | Price 0.92 | Shares 146,400
Buy 8 Sep 2008
Value US$118,750.00 | Price 0.95 | Shares 125,000
Buy 4 Sep 2008
Value US$49,507.35 | Price 0.95 | Shares 52,113
Buy 3 Sep 2008
Value US$6,383.52 | Price 0.93 | Shares 6,864
Buy 2 Sep 2008
Value US$300,901.50 | Price 0.93 | Shares 323,550
Buy 27 Aug 2008
Value US$84,974.65 | Price 0.95 | Shares 89,447
Buy 15 Aug 2008
Value US$108,330.40 | Price 0.95 | Shares 114,032
Buy 14 Aug 2008
Value US$5,445.90 | Price 0.90 | Shares 6,051
Buy 7 Aug 2008
Value US$89,552.40 | Price 0.98 | Shares 91,380
Buy 6 Aug 2008
Value US$360.00 | Price 0.90 | Shares 400
Sale 31 May 2006
Value US$6,159,094.59 | Price 9.79 | Shares 629,121
Buy 31 May 2006
Value US$1,982.00 | Price 9.91 | Shares 200
Buy 31 May 2006
Value US$7,920.00 | Price 9.90 | Shares 800
Sale 31 May 2006
Value US$6,159,094.59 | Price 9.79 | Shares 629,121
Buy 26 May 2006
Value US$2,475.00 | Price 9.90 | Shares 250
Buy 26 May 2006
Value US$1,980.00 | Price 9.90 | Shares 200
Buy 26 May 2006
Value US$494.50 | Price 9.89 | Shares 50
Buy 26 May 2006
Value US$20,280.00 | Price 10.14 | Shares 2,000
Buy 26 May 2006
Value US$968.00 | Price 9.68 | Shares 100
Buy 26 May 2006
Value US$967.00 | Price 9.67 | Shares 100
Buy 26 May 2006
Value US$2,907.00 | Price 9.69 | Shares 300
Buy 26 May 2006
Value US$5,790.00 | Price 9.65 | Shares 600
Buy 25 May 2006
Value US$797.44 | Price 8.96 | Shares 89
Buy 25 May 2006
Value US$26,111.67 | Price 8.97 | Shares 2,911
Buy 25 May 2006
Value US$15,283.00 | Price 8.99 | Shares 1,700
Buy 25 May 2006
Value US$56,700.00 | Price 9.00 | Shares 6,300
Buy 25 May 2006
Value US$22,500.00 | Price 9.00 | Shares 2,500
Buy 25 May 2006
Value US$45,250.00 | Price 9.05 | Shares 5,000
Buy 25 May 2006
Value US$15,300.00 | Price 9.00 | Shares 1,700
Buy 25 May 2006
Value US$7,184.00 | Price 8.98 | Shares 800
Buy 25 May 2006
Value US$8,990.00 | Price 8.99 | Shares 1,000
Sale 17 Feb 2006
Value US$60,552.00 | Price 16.82 | Shares 3,600
Buy 14 Feb 2006
Value US$15,590.00 | Price 15.59 | Shares 1,000
Buy 20 Oct 2005
Value US$1,500,000.70 | Price 2.65 | Shares 566,038
Buy 8 Apr 2005
Value US$1,980,000.00 | Price 2.20 | Shares 900,000
Planned sale 3 Jan 2005
Value US$34,680.00 | Price 3.40 | Shares 10,200
Planned sale 3 Jan 2005
Value US$16,254.24 | Price 3.39 | Shares 4,800
Planned sale 3 Jan 2005
Value US$2,052.00 | Price 3.42 | Shares 600
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-05-16 2014-05-16 S Sale OCAMPO CHRISTINE

Vice President, Finance

Officer
21,664 +16.8%
345.52
US$1,254,719 		21,664 +16.8% 345.52 US$1,254,719
2013-12-19 2013-12-17 B Purchase PALEKAR ROHAN

SVP & Chief Commercial Officer

Officer
17,429 -16.8%
344.09
US$1,634,897 		17,429 -16.8% 344.09 US$1,634,897
2013-11-05 2013-11-04 B Purchase PALEKAR ROHAN

SVP & Chief Commercial Officer

Officer
65,349 +44.3%
323.17
US$2,280,016 		65,349 +44.3% 323.17 US$2,280,016
2012-05-14 2012-05-10 B Purchase Siffert Joao MD

SVP, R&D

Officer
2,700 +9.2%
2.96
US$7,992 		2,700 +9.2% 2.96 US$7,992
2012-03-07 2012-03-06 B Purchase MATHEWS CHARLES Non-Executive Director
5,000 +inf%
2.69
US$13,473 		5,000 +inf% 2.69 US$13,473
2012-03-07 2012-03-06 B Purchase OCAMPO CHRISTINE

Vice President, Finance

Officer
3,000 +inf%
2.60
US$7,795 		3,000 +inf% 2.60 US$7,795
2010-11-10 2010-11-09 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,200,000 -15.2%
4.81
US$5,773,920 		1,200,000 -15.2% 4.81 US$5,773,920
2010-11-10 2010-11-08 S Sale Clarus Lifesciences I, L.P. Large shareholder
44,626 -0.6%
5.10
US$227,593 		44,626 -0.6% 5.10 US$227,593
2010-11-05 2010-11-05 S Sale Clarus Lifesciences I, L.P. Large shareholder
332,572 -4.0%
4.80
US$1,597,377 		332,572 -4.0% 4.80 US$1,597,377
2010-11-05 2010-11-03 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,400,106 -14.5%
4.52
US$6,332,539 		1,400,106 -14.5% 4.52 US$6,332,539
2010-11-02 2010-11-02 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,290,871 -11.8%
4.49
US$5,800,400 		1,290,871 -11.8% 4.49 US$5,800,400
2010-11-02 2010-11-01 S Sale Clarus Lifesciences I, L.P. Large shareholder
2,478,142 -18.5%
5.36
US$13,273,424 		2,478,142 -18.5% 5.36 US$13,273,424
2010-11-02 2010-10-29 S Sale Clarus Lifesciences I, L.P. Large shareholder
1,424,947 -9.6%
5.06
US$7,215,647 		1,424,947 -9.6% 5.06 US$7,215,647
2010-10-12 2010-10-11 S Sale Clarus Lifesciences I, L.P. Large shareholder
311,000 -2.1%
3.52
US$1,093,445 		311,000 -2.1% 3.52 US$1,093,445
2010-10-12 2010-10-08 S Sale Clarus Lifesciences I, L.P. Large shareholder
240,838 -1.6%
3.47
US$836,792 		240,838 -1.6% 3.47 US$836,792
2010-07-15 2010-07-13 S Sale Clarus Lifesciences I, L.P. Large shareholder
165,000 -1.1%
3.53
US$583,143 		165,000 -1.1% 3.53 US$583,143
2009-10-13 2009-10-13 S Sale Moorin Jay Large shareholder
547,135 -7.1%
2.23
US$1,220,111 		547,135 -7.1% 2.23 US$1,220,111
2009-10-13 2009-10-12 S Sale Moorin Jay Large shareholder
427,145 -5.3%
2.12
US$905,547 		427,145 -5.3% 2.12 US$905,547
2009-10-13 2009-10-09 S Sale Moorin Jay Large shareholder
804,712 -9.0%
2.46
US$1,979,592 		804,712 -9.0% 2.46 US$1,979,592
2009-08-13 2009-08-11 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
232,450 -2.8%
3.37
US$783,938 		232,450 -2.8% 3.37 US$783,938
2009-08-13 2009-08-11 S Sale Moorin Jay Large shareholder
894,120 -9.1%
3.58
US$3,200,950 		894,120 -9.1% 3.58 US$3,200,950
2009-08-13 2009-08-11 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
49,800 -0.6%
4.05
US$201,690 		49,800 -0.6% 4.05 US$201,690
2009-08-03 2009-07-31 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
1,400 -0.0%
2.20
US$3,080 		1,400 -0.0% 2.20 US$3,080
2009-08-03 2009-07-30 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
142,366 -1.7%
2.29
US$326,445 		142,366 -1.7% 2.29 US$326,445
2009-08-03 2009-07-29 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
145,500 -1.7%
2.28
US$331,245 		145,500 -1.7% 2.28 US$331,245
2009-08-03 2009-07-28 S Sale Vivo Ventures Fund VI, L.P. Large shareholder
122,100 -1.4%
2.42
US$295,714 		122,100 -1.4% 2.42 US$295,714
2008-10-24 2008-10-22 B Purchase Moorin Jay Large shareholder
10,600 +0.1%
0.48
US$5,088 		10,600 +0.1% 0.48 US$5,088
2008-10-15 2008-10-15 B Purchase Moorin Jay Large shareholder
6,465 +0.1%
0.49
US$3,168 		6,465 +0.1% 0.49 US$3,168
2008-10-15 2008-10-14 B Purchase Moorin Jay Large shareholder
32,300 +0.3%
0.50
US$16,150 		32,300 +0.3% 0.50 US$16,150
2008-10-15 2008-10-10 B Purchase Moorin Jay Large shareholder
73,551 +0.8%
0.45
US$33,098 		73,551 +0.8% 0.45 US$33,098
2008-10-10 2008-10-09 B Purchase Moorin Jay Large shareholder
41,385 +0.4%
0.48
US$19,865 		41,385 +0.4% 0.48 US$19,865
2008-10-10 2008-10-08 B Purchase Moorin Jay Large shareholder
114,384 +1.2%
0.50
US$57,192 		114,384 +1.2% 0.50 US$57,192
2008-10-10 2008-10-07 B Purchase Moorin Jay Large shareholder
21,318 +0.2%
0.48
US$10,233 		21,318 +0.2% 0.48 US$10,233
2008-09-17 2008-09-17 B Purchase Moorin Jay Large shareholder
413,217 +4.5%
0.80
US$330,574 		413,217 +4.5% 0.80 US$330,574
2008-09-17 2008-09-16 B Purchase Moorin Jay Large shareholder
17,387 +0.2%
0.76
US$13,214 		17,387 +0.2% 0.76 US$13,214
2008-09-17 2008-09-15 B Purchase Moorin Jay Large shareholder
244,449 +2.8%
0.85
US$207,782 		244,449 +2.8% 0.85 US$207,782
2008-09-10 2008-09-10 B Purchase Moorin Jay Large shareholder
48,103 +0.5%
0.91
US$43,774 		48,103 +0.5% 0.91 US$43,774
2008-09-10 2008-09-09 B Purchase Moorin Jay Large shareholder
146,400 +1.7%
0.92
US$134,688 		146,400 +1.7% 0.92 US$134,688
2008-09-10 2008-09-08 B Purchase Moorin Jay Large shareholder
125,000 +1.5%
0.95
US$118,750 		125,000 +1.5% 0.95 US$118,750
2008-09-04 2008-09-04 B Purchase Moorin Jay Large shareholder
52,113 +0.6%
0.95
US$49,507 		52,113 +0.6% 0.95 US$49,507
2008-09-04 2008-09-03 B Purchase Moorin Jay Large shareholder
6,864 +0.1%
0.93
US$6,384 		6,864 +0.1% 0.93 US$6,384
2008-09-04 2008-09-02 B Purchase Moorin Jay Large shareholder
323,550 +4.0%
0.93
US$300,902 		323,550 +4.0% 0.93 US$300,902
2008-08-29 2008-08-27 B Purchase Moorin Jay Large shareholder
89,447 +1.1%
0.95
US$84,975 		89,447 +1.1% 0.95 US$84,975
2008-08-18 2008-08-15 B Purchase Moorin Jay Large shareholder
114,032 +1.4%
0.95
US$108,330 		114,032 +1.4% 0.95 US$108,330
2008-08-18 2008-08-14 B Purchase Moorin Jay Large shareholder
6,051 +0.1%
0.90
US$5,446 		6,051 +0.1% 0.90 US$5,446
2008-08-08 2008-08-07 B Purchase Moorin Jay Large shareholder
91,380 +1.2%
0.98
US$89,552 		91,380 +1.2% 0.98 US$89,552
2008-08-08 2008-08-06 B Purchase Moorin Jay Large shareholder
400 +0.0%
0.90
US$360 		400 +0.0% 0.90 US$360
2006-06-07 2006-05-31 S Sale SILVERSTEIN JONATHAN Non-Executive Director
629,121 -26.9%
9.79
US$6,159,095 		629,121 -26.9% 9.79 US$6,159,095
2006-06-02 2006-05-31 B Purchase Podlesak Dennis Non-Executive Director
200 +2.8%
9.91
US$1,982 		200 +2.8% 9.91 US$1,982
2006-06-02 2006-05-31 S Sale ORBIMED ADVISORS LLC Non-Executive Director
629,121 -26.9%
9.79
US$6,159,095 		629,121 -26.9% 9.79 US$6,159,095
2006-06-02 2006-05-31 B Purchase Podlesak Dennis Non-Executive Director
800 +12.4%
9.90
US$7,920 		800 +12.4% 9.90 US$7,920
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
250 +inf%
9.90
US$2,475 		250 +inf% 9.90 US$2,475
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
200 +400.0%
9.90
US$1,980 		200 +400.0% 9.90 US$1,980
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
50 +inf%
9.89
US$494 		50 +inf% 9.89 US$494
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
100 +2.0%
9.68
US$968 		100 +2.0% 9.68 US$968
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
100 +2.0%
9.67
US$967 		100 +2.0% 9.67 US$967
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
300 +6.4%
9.69
US$2,907 		300 +6.4% 9.69 US$2,907
2006-05-26 2006-05-26 B Purchase Kaye Randall

VP of Medical Affairs

Officer
2,000 +inf%
10.14
US$20,280 		2,000 +inf% 10.14 US$20,280
2006-05-26 2006-05-26 B Purchase HANSON GREGORY P

Vice President, CAO

Officer
600 +14.8%
9.65
US$5,790 		600 +14.8% 9.65 US$5,790
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
89 +0.0%
8.96
US$797 		89 +0.0% 8.96 US$797
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
2,911 +1.1%
8.97
US$26,112 		2,911 +1.1% 8.97 US$26,112
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
1,700 +0.7%
8.99
US$15,283 		1,700 +0.7% 8.99 US$15,283
2006-05-25 2006-05-25 B Purchase PUNTORIERO MICHAEL J

Senior VP, Finance, CFO

Officer
2,500 +44.4%
9.00
US$22,500 		2,500 +44.4% 9.00 US$22,500
2006-05-25 2006-05-25 B Purchase Katkin Keith

Sr. V.P. of Sales & Marketing

Officer
1,700 +212.5%
9.00
US$15,300 		1,700 +212.5% 9.00 US$15,300
2006-05-25 2006-05-25 B Purchase BRANDT ERIC

President, CEO & Director

Executive Director
6,300 +2.5%
9.00
US$56,700 		6,300 +2.5% 9.00 US$56,700
2006-05-25 2006-05-25 B Purchase EMANUELE ROBERT MARTIN

V P, Business Development

Officer
1,000 +inf%
8.99
US$8,990 		1,000 +inf% 8.99 US$8,990
2006-05-25 2006-05-25 B Purchase PUNTORIERO MICHAEL J

Senior VP, Finance, CFO

Officer
5,000 +800.0%
9.05
US$45,250 		5,000 +800.0% 9.05 US$45,250
2006-05-25 2006-05-25 B Purchase Katkin Keith

Sr. V.P. of Sales & Marketing

Officer
800 +inf%
8.98
US$7,184 		800 +inf% 8.98 US$7,184
2006-02-22 2006-02-17 S Sale SIRCAR JAGADISH C

VP of Drug Discovery

Officer
3,600 -22.2%
16.82
US$60,552 		3,600 -22.2% 16.82 US$60,552
2006-02-15 2006-02-14 B Purchase Mazzo David J Non-Executive Director
1,000 +15.5%
15.59
US$15,590 		1,000 +15.5% 15.59 US$15,590
2005-10-24 2005-10-20 B Purchase SILVERSTEIN JONATHAN Non-Executive Director
566,038 +6.5%
2.65
US$1,500,001 		566,038 +6.5% 2.65 US$1,500,001
2005-04-12 2005-04-08 B Purchase SILVERSTEIN JONATHAN Non-Executive Director
900,000 +11.4%
2.20
US$1,980,000 		900,000 +11.4% 2.20 US$1,980,000
2005-01-03 2005-01-03 PlS Planned sale HANSEN JOHN DAVID

V.P. of Corporate Development

Officer
10,200 -40.5%
3.40
US$34,680 		10,200 -40.5% 3.40 US$34,680
2005-01-03 2005-01-03 PlS Planned sale HANSEN JOHN DAVID

V.P. of Corporate Development

Officer
4,800 -16.0%
3.39
US$16,254 		4,800 -16.0% 3.39 US$16,254
2005-01-03 2005-01-03 PlS Planned sale HANSEN JOHN DAVID

V.P. of Corporate Development

Officer
600 -3.8%
3.42
US$2,052 		600 -3.8% 3.42 US$2,052
Explore more

More insider trading research around Avanir Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America